Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

<p>Abstract</p> <p>Background</p> <p>Ipilimumab and vemurafenib have both been shown to improve survival in phase III trials of patients with metastatic melanoma. Although vemurafenib is associated with a rapid onset of activity, responses are often of limited duration. Conversely, responses to ipil...

Description complète

Détails bibliographiques

Auteurs principaux:	Ascierto Paolo A, Simeone Ester, Giannarelli Diana, Grimaldi Antonio M, Romano Anna, Mozzillo Nicola
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2012-05-01
Collection:	Journal of Translational Medicine
Sujets:	Dabrafenib Disease progression Ipilimumab Treatment sequencing Vemurafenib
Accès en ligne:	http://www.translational-medicine.com/content/10/1/107
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!